nach oben

Erschienen in:

11.07.2019 | Original Paper

Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program

verfasst von: Benjamin T. Allaire, Donatus Ekweme, Thomas J. Hoerger, Amy DeGroff, Sun Hee Rim, Sujha Subramanian, Jacqueline W. Miller

Erschienen in: Cancer Causes & Control | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Patient navigation (PN) services have been shown to improve cancer screening in disparate populations. This study estimates the cost-effectiveness of implementing PN services within the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).

Methods

We adapted a breast cancer simulation model to estimate a population cohort of women aged 40–64 years from the NBCCEDP through their lifetime. We incorporated their screening frequency and screening and diagnostic costs.

Results

Within the NBCCEDP, Program with PN (vs. No PN) resulted in a greater number of mammograms per woman (4.23 vs. 4.14), lower lifetime mortality from breast cancer (3.53% vs. 3.61%), and fewer missed diagnostic resolution per woman (0.017 vs. 0.025). The estimated incremental cost-effectiveness ratios for a Program with PN was $32,531 per quality-adjusted life-years relative to Program with No PN.

Conclusions

Incorporating PN services within the NBCCEDP may be a cost-effective way of improving adherence to screening and diagnostic resolution for women who have abnormal results from screening mammography. Our study highlights the value of supportive services such as PN in improving the quality of care offered within the NBCCEDP.

U.S. Cancer Statistics Working Group (2017) United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. www.cdc.gov/uscs

Siu AL, USPSTF (2016) Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 164(4):279–296CrossRefPubMed

Oeffinger KC, Fontham ET, Etzioni R et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral

White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC (2017) Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 66(8):201–206. https://doi.org/10.15585/mmwr.mm6608a1 CrossRefPubMedPubMedCentral

CDC Division of Cancer Prevention and Control. National Breast and Cervical Cancer Early Detection Program (NBCCEDP), About the Program, Accomplishments [Internet]. CDC Cancer Division. www.cdc.gov/cancer/nbccedp/about.htm

Bhanegaonkar A, Madhavan SS, Khanna R, Remick SC (2012) Declining mammography screening in a state Medicaid Fee-for-Service program: 1999–2008. J Womens Health (Larchmt). 21(8):821–829CrossRefPubMedCentral

Peipins LA, Graham S, Young R, Lewis B, Foster S, Flanagan B, Dent A (2011) Time and distance barriers to mammography facilities in the Atlanta metropolitan area. J Community Health 36(4):675–683CrossRefPubMedPubMedCentral

Alexandraki I, Mooradian AD (2010) Barriers related to mammography use for breast cancer screening among minority women. J Natl Med Assoc 102(3):206–218CrossRefPubMed

Davis JL, Bynum SA, Katz RV, Buchanan K, Green BL (2012) Sociodemographic differences in fears and mistrust contributing to unwillingness to participate in cancer screenings. J Health Care Poor Underserved 23(4 Suppl):67–76CrossRefPubMedPubMedCentral

10.

Peipins LA, Soman A, Berkowitz Z, White MC (2012) The lack of paid sick leave as a barrier to cancer screening and medical care-seeking: results from the National Health Interview Survey. BMC Public Health 12:520CrossRefPubMedPubMedCentral

11.

Stanley S, Arriola KJ, Smith S, Hurlbert M, Ricci C, Escoffery C (2013) Reducing barriers to breast cancer care through Avon patient navigation programs. J Public Health Manag Pract. 19(5):461–467. https://doi.org/10.1097/phh.0b013e318276e272 CrossRefPubMed

12.

Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D (2012) Denver Patient Navigation Research Program. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev 21(10):1629–1638CrossRefPubMedPubMedCentral

13.

Natale-Pereira Ana, Enard Kimberly R, Nevarez Lucinda, Jones Lovell A (2011) The role of patient navigators in eliminating health disparities. Cancer 117(15):3543–3552PubMedPubMedCentral

14.

Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC (2008) Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 112(3):626–635CrossRefPubMed

15.

Hoerger TJ, Ekwueme DU, Miller JW et al (2011) Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med 40(4):397–404. https://doi.org/10.1016/j.amepre.2010.12.017 CrossRefPubMedPubMedCentral

16.

Subramanian S, Ekwueme DU, Gardner JG, Trogdon J (2009) Developing and testing a cost-assessment tool for cancer screening programs. Am J Prev Med 37(3):242–247. https://doi.org/10.1016/j.amepre.2009.06.002 CrossRefPubMed

17.

Trogdon JG, Ekwueme DU, Subramanian S, Crouse W (2014) Economies of scale in federally-funded state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs. Health Care Manag Sci 17:321–330CrossRefPubMed

18.

Rim S, Allaire B, Ekwueme D, Miller J, Subramanian S, Hall I, Hoerger T (2019) Cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control. https://doi.org/10.1007/s10552-019-01178-y CrossRefPubMed

19.

Cronin KA, Yu B, Krapcho M et al (2005) Modeling the dissemination of mammography in the U.S. Cancer Causes Control 16:701–712CrossRefPubMed

20.

Plevritis SK, Salzman P, Sigal BM, Glynn P (2007) A natural history model of stage progression applied to breast cancer. Stat Med 26:581–595CrossRefPubMed

21.

Feuer EJ (2006) Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem. J Natl Cancer Inst Monogr 36:2–6CrossRef

22.

Wells KJ, Battaglia TA, Dudley DJ et al (2008) Patient navigation: state of the art or is it science? Cancer 113(8):1999–2010CrossRefPubMedPubMedCentral

23.

Battaglia TA, Bak SM, Heeren T et al (2012) Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev 21(10):1645–1654CrossRefPubMedPubMedCentral

24.

Clark CR, Baril N, Kunicki M et al (2009) Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women’s Health Demonstration Project. J Womens Health 18(5):677–690CrossRef

25.

Markossian TW, Darnell JS, Calhoun EA (2012) Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomarkers Prev 21(10):1691–1700CrossRefPubMedPubMedCentral

26.

Battaglia TA, Roloff K, Posner MA, Freund KM (2007) Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer 109(2 Suppl):359–367CrossRefPubMed

27.

Ferrante JM, Chen PH, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85(1):114–124CrossRefPubMed

28.

Miller JW, Hanson V, Johnson GD, Royalty JE, Richardson LC (2014) From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer 120:2549–2556. https://doi.org/10.1002/cncr.28823 CrossRefPubMedPubMedCentral

29.

Hoffman HJ, LaVerda NL, Young HA et al (2012) Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. Cancer Epidemiol Biomarkers Prev 21(10):1655–1663CrossRefPubMedPubMedCentral

30.

Freeman HP, Rodriguez RL (2011) History and principles of patient navigation. Cancer 117:3539–3542CrossRefPubMedPubMedCentral

31.

Percac-Lima S, Ashburner JM, Bond B, Oo SA, Atlas SJ (2013) Decreasing disparities in breast cancer screening in refugee women using culturally tailored patient navigation. J Gen Intern Med 28(11):1463–1468CrossRefPubMedPubMedCentral

32.

Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ (2015) Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Womens Health (Larchmt) 24(2):138–143CrossRef

33.

Donelan K, Mailhot JR, Dutwin D et al (2011) Patient perspectives of clinical care and patient navigation in follow-up of abnormal mammography. J Gen Intern Med 26(2):116–122CrossRefPubMed

34.

Molina Y, Kim S, Berrios N, Calhoun EA (2015) Medical mistrust and patient satisfaction with mammography: the mediating effects of perceived self-efficacy among navigated African American women. Health Expect 18(6):2941–2950CrossRefPubMed

35.

Levy AR, Bruen BK, Ku L (2012) Health Care Reform and Women’s Insurance Coverage for Breast and Cervical Cancer Screening. [Erratum appears in Prev Chronic Dis 2012;9. http://www.cdc.gov/pcd/issues/2012/12_0069e.htm. Prev Chronic Dis 9:120069. https://doi.org/10.5888/pcd9.120069 CrossRef

36.

Dohan D, Schrag D (2005) Using navigators to improve care of underserved patients: current practices and approaches. Cancer 104(4):848–855CrossRefPubMed

Titel: Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program
verfasst von: Benjamin T. Allaire
Donatus Ekweme
Thomas J. Hoerger
Amy DeGroff
Sun Hee Rim
Sujha Subramanian
Jacqueline W. Miller
Publikationsdatum: 11.07.2019
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 9/2019
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-019-01200-3

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program

Abstract

Objectives

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Patterns of comorbidities in women with breast cancer: a Canadian population-based study

Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

Trajectories of body mass index, from adolescence to older adulthood, and pancreatic cancer risk; a population-based case–control study in Ontario, Canada

Dose–risk relationships between cigarette smoking and ovarian cancer histotypes: a comprehensive meta-analysis

Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women

Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie